1 Chao M,Wei J,Lo YC,et al.Dose cluster model parameterization of the parotid gland in irradiation of head and neck cancer[J].Australas Phys Eng Sci Med,2020,43(1):143-153. 2 Chen X,Wu H,Schultz CJ,et al.Effective volume of parotid glands for assessing radiation injury during radiation therapy for head and neck cancer[J].Int J Radiat Oncol,2019,105(Suppl):S31-S32. 3 Hottat N,Jani J,Badr D,et al.Diffusion-weighted MRI in the evaluation of early-stage breast cancer treated with a short preoperative tadiotherapy:preliminary results[J].J Belg Soc Radiol,2023,107(1):8. 4 Zhao DW,Teng F,Meng LL,et al.Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients[J].Radiother Oncol,2023,184:109683. 5 Xiao XT,Wu YS,Chen YP,et al.Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy[J].Cancer Med,2022,12(2):1399-1408. 6 Li M,Zhang J,Zha Y,et al.A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy[J].BMC Oral Health,2022,22(1):239. 7 Shen M,Lin X,Yang C,et al.Potential predictive value of IVIM MR for xerostomia in nasopharyngeal carcinoma[J].Radiother Oncol,2024,10:110323. 8 Cai XL,Hu J,Shi JT,et al.Contouring the accessory parotid gland and major parotid glands as a single organ at risk during nasopharyngeal carcinoma radiotherapy[J].Front Oncol,2022,12:958961. 9 Tan WY,Yang M,Dai Y,et al.Geometric changes in the parotid,submandibular,and thyroid glands during intensity modulated radiotherapy for nasopharyngeal carcinoma.cohort study[J].J Anal Oncol,2020,9:46-55. 10 赖美春,刘秀芳,黄丹,等.鼻咽癌患者放疗致口腔黏膜反应的护理效果评价[J].中国继续医学教育,2019,11(28):170-172. 11 Tasaka S,Jingu K,Takahashi N,et al.The long-term recovery of parotid glands in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J].Front Oncol,2021,11:665837. 12 Lee A,Ng W,Pan J,et al.International guideline for the delineation of the clinical target volumes(CTV)for nasopharyngeal carcinoma[J].Radiotherapy Oncol,2018,126(1):25-36. 13 Zheng L,Tong L,Du F,et al.Effect of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy on parotid gland function and quality of life in patients with nasopharyngeal carcinoma[J].Am J Transl Res,2021,13(5):5272-5279. 14 Fan WJ,Teng F,Luo YR,et al.Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients:a preliminary study[J].Strahlenther Onkol,2020,196(6):530-541. 15 Pan XB,Liu Y,Li L,et al.Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy[J].Aging(Albany NY),2020,12(2):1857-1866. 16 中国医师协会放射肿瘤治疗医师分会,中华医学会放射肿瘤治疗学分会.中国鼻咽癌放射治疗指南(2020版)[J].中华肿瘤防治杂志,2021,28(3):167-177. 17 Pan XB,Liu Y,Huang ST,et al.Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy[J].Medicine,2019,98(36):e17030. 18 Lou J,Huang P,Ma C,et al.Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma[J].J Appl Clin Med Phys,2018,19(3):251-260. 19 Zhang Y,Liu X,Lin C,et al.Pattern of geometric changes of parotid gland in conventional and intensity-modulated radiotherapy in nasopharyngeal cancer patients[J].Radiother Pract,2018,17(3):274-278. 20 Hiraoka S,Yoshimura M,Nakajima A,et al.Long-term outcomes of stimulated salivary flow and xerostomia after definitive intensity-modulated radiation therapy for patients with head and neck cancer[J].J Radiat Res,2024,65(1):71-77. 21 Chinnery TA,Lang P,Nichols AC,et al.Predicting the need for a replan in oropharyngeal cancer:a radiomic,clinical,and dosimetric model[J].Med Phys,2023,51(5):3510-3520. 22 Castelli J,Thariat J,Benezery K,et al.Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer:a phase 3 randomized clinical trial[J].Jama Oncol,2023,9(8):1056-1064. 23 Wang M,Xi Y,Wang L,et al.Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma[J]. Radiat Oncol,2024,19(1):26. 24 Yang M,Xie H,Hou Z,et al.Beneficial role of customized intraoral stents in radiotherapy for nasopharyngeal carcinoma[J].J Clin Oncol,2022,40(16_suppl):e18642. 25 Cavallo A,Iacovelli NA,Facchinetti N,et al.Modelling radiation-induced salivary dysfunction during IMRT and chemotherapy for nasopharyngeal cancer patients[J].Cancers(Basel),2021,13(16):3983. 26 Lu S,Fan H,Hu X,et al.Dosimetric comparison of helical tomotherapy,volume-modulated arc therapy,and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma[J].Front Oncol,2021,11:764946. 27 Fan CM,Qu HK,Xiong F,et al.CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling[J].Cancer Lett,2020,496:41-56. |